Is male circumcision as good as the HIV vaccine we've been waiting for?

Future HIV Therapy

Volumn 2, Issue 1, 2008, Pages 1-7

  Klausner, Jeffrey D ^a   Wamai, Richard G ^b   Bowa, Kasonde ^c   Agot, Kawango ^d,e,f   Kagimba, Jesse ^g   Halperin, Daniel T ^h  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY TEACHING HOSPITAL   (Zambia)

^d UNIVERSITY OF NAIROBI   (Kenya)

^e UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^f University of Nairobi Lumumba Health Center   (Kenya)

^g Center for Population and Development Studies ^*

^h HARVARD CENTER FOR POPULATION AND DEVELOPMENT STUDIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; HUMAN IMMUNODEFICIENCY VIRUS VACCINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AFRICA SOUTH OF THE SAHARA; CIRCUMCISION; CLINICAL TRIAL; CONDOM; CONTROLLED CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; CULTURAL FACTOR; EDITORIAL; GOVERNMENT; HEALTH CARE ACCESS; HEALTH CARE AVAILABILITY; HEALTH CARE DELIVERY; HEALTH CARE ORGANIZATION; HEALTH PROGRAM; HETEROSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INFECTION PREVENTION; INFECTION RISK; INFECTION SENSITIVITY; INFORMATION DISSEMINATION; INTERPERSONAL COMMUNICATION; LANGERHANS CELL; MEDICAL RESEARCH; PATIENT ATTITUDE; PATIENT COUNSELING; PATIENT EDUCATION; PREPUCE; PUBLIC HEALTH SERVICE; RANDOMIZED CONTROLLED TRIAL; REPRODUCTIVE HEALTH; RESEARCH SUBJECT; RISK REDUCTION; SEXUAL BEHAVIOR; SEXUAL TRANSMISSION; UNITED STATES; UTERINE CERVIX CANCER; VIRUS INFECTION; VIRUS TRANSMISSION; WART VIRUS;

EID: 40349089978     PISSN: 17469600     EISSN: None     Source Type: Journal    
DOI: 10.2217/17469600.2.1.1     Document Type: Editorial

References (41)

1. UNAIDS. AIDS Epidemic Update, December 2007. www.unaids.org/en/HIVdata/ 2007EpiUpdate/default.asp
2. Bongaarts J, Reining P, Way P, Conant F: The relationship between male circumcision and HIV infection in African populations. AIDS 3(6), 373-377 (1989).
3. Moses S, Bradley JE, Nagelkerke NJ, Ronald AR, Ndinya-Achola JO, Plummer FA. Geographical patterns of male circumcision practices in Africa: association with HIV seroprevalence. Int. J. Epidemiol. 19, 693-697 (1990).
4. Caldwell J, Caldwell P: The African AIDS epidemic. Scientific American 274, 62-68 (1996).
5. Halperin DT Bailey RC: Male circumcision and HIV infection: ten years and counting. Lancet 354, 1813-1815 (1999). www.circumcisioninfo.com/halperin_bailey.html
6. Auvert B, Taljaard. D, Lagarde E, Sobngwi-Tambekou J, Sitta R, Puren A: Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial. PLoS Med. 2 (11); E298 (2005).
7. Bailey RC, Moses S, Parker CB et al.: Male circumcision, for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial. Lancet 369(9562), 643-56 (2007).
8. Gray RH, Kigozi G, Serwadda D et al.: Male circumcision for HIV prevetition in men in Rakai, Uganda: a randomised trial. Lancet 369(9562), 657-666 (2007).
9. Cohen J: Male circumcision thwarts HIV infection. Science 309, 860 (2005).
10. Weiss HA, Quigley MA. Hayes RJ: Male circumcision and risk of HIV infection in sub-Saharan Affica: a systematic review and meta-analysis. AIDS 14, 2361-2370 (2000).
11. USAID/AIDSMARK: Male circumcision: current epidemiological and field evidence; program and policy implications for HIV prevention and reproductive health. Washington, USA 2003. www.dec.org/pdf_docs/ PNACS892.pdf
12. Weiss HA, Halperin DT, Bailey RC, Hayes R, Schmid G, Hankins C: Male circumcision for HIV prevention: from evidence to action? AIDS 21, 1-8 (2007).
13. Drain PK, Halperin DT, Hughes JP, Klausner JD, Bailey RC: Male circumcision, religion and infections diseases: an ecologic analysis of 118 developing countries.BioMed Central 6,172 (2006).
14. Buve A, Carael M, Hayes RJ et al.: The multicentre study on factors determining the differential spread of HIV in four African cities: summary and conclusions. AIDS 15(Suppl. 4), S127-S131 (2001).
15. McCoombe SG, Short RV: Potential HIV-1 target cells in the human penis. AIDS 20, 1491-1495 (2006).
16. Donoval BA, Landay AL, Moses S et al.: HIV-1 target cells in foreskins of African men with varying histories of sexually transmitted infections. Am. J. Clin. Pathol. 125, 386-391 (2006).
17. Weiss HA, Thomas SL, Munabi SK, Hayes RJ: Male circumcision and risk of syphilis, chancroid, and genital herpes: a systematic review and meta-analysis. Sex. Transm. Infect. 82, 101-109; discussion 110 (2006).
18. Manhart L, Holmes KK: Randomized controlled trials of individual-level, population-level, and multilevel interventions for preventing sexually transmitted infections: what has worked? J. Infect. Dis. 191, S7-S24 (2005).
19. Shelton J: Estimated protection too conservative. Plos Med. 3, E65 (2006) www.circumcisioninfo.com/halperin_bailey.html
20. Lavreys L, Rakwan JP, Thompson ML et al.: Effect of circumcision on incidence of HIV-1 and other sexually transmitted diseases: a prospective cohort study of trucking company employees in Kenya. J Infect. Dis. 180, 330-336 (1999).
21. Reynolds SJ, Shepherd ME, Risbud AR et al.: Male circumcision and risk of HIV-1 and other sexually transmitted infections in India. Lancet 363, 109-1040 (2004).
22. Quinn TC, Wawer MJ, Sewankambo N et al.: Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. N. Engl. J. Med. 342, 921-929 (2000).
23. Cassell MM, Halperin DT, Shelton JD, Stanton D: Risk compensation: the Achilles hed of innovations in HIV prevention? Br. Med. J. 332, 605-607 (2006).
24. Agot EK, Kiarie JN, Nguyen HQ et al.: Male circumcision in Siaya and Bondo Districts, Kenya: a prospective cohort study to assess behavioral disinhibition following circumcision. J. Acq. Imm. Def. Synd. 44, 66-70 (2007).
25. Allen A: Vaccine: the controversial story of medicine's greatest lifesaver. WW Norton, NY, USA (2007).
26. Potts M: Circumcision and HIV. Lancet 355, 926-927 (2000).
27. Williams BG, Lloyd-Smith JO, Gouws E et al.: The potential impact of male circumcision on HIV in sub-Saharan Africa. PLoS-Med. 3, E262 (2006).
28. Kahn JG, Marseille E, Auvert B: Cost-effectiveness of male circumcision for HIV prevention in a South African setting. PLoS Med. 3, E 517 -(2006). http://dx.doi.org/10.1371/journal.pimed.0030517.
29. Westercamp, N, Bailey RC; Acceptability of male circumcision for prevention of HIV/AIDS in sub-Saharan.Africa. a review. AIDS Behav. 11 (3), 341-55 (2007).
30. Halperin DT: Cut and dry: feasibility and. acceptability of reviving male circumcision and introducing dry sex prevention in Botswana and South Africa. Published abstracts of the American Anthropological Association 99th Annual Meeting. San Francisco, CA, USA 18 November 2000.
31. Halperin DT. Allen A. Is poverty the root cause of African AIDS? AIDS Anal. Afr. 11 (2000). http://sfgate.com/cgi-bin/article.cgi?file=/ chronicle/archive/2000/11/30/ED1
32. Jewkes R, Dunkle K, Nduna M et al.: Factors associated with HIV sero-positivity in young, rural South African men. Int. J. Epidem. http://ije.oxfordjournals.org/cgi/content/abstract/dy1217v1?ct=ct
33. Timberg C: In Swaziland, science revives an old rite. Washington Post; December 26, 2005. www.washingtonpost.com/wp-dyn/content/article/2005/ 12/25/AR2005122500749.html
34. Harrison R: Circumcision makes comeback in AIDS-hit Swaziland, Reuters New Media, February 24, 2006. http://www.aegis.com/news/re/2006/ RE060234.html
35. Bailis SA, Halperin DT. Male circumcision: time to re-examine the evidence. Br. Med. J. 14, 179-80 (2006). www.studentbmj.com/ issues/06/05/editorials/179.php
36. Castellsagué X, Bosch FX, Munoz N et al.: Male circumcision, penile human papillomavirus infection; and cervical cancer in female partners. N. Engl. J. Med. 346, 1105-1112 (2002).
37. NVHO/ICO Information Centre on HPV and Cervical Cancer. www.who.int/ hpvcentre/en/
38. WHO/UNAIDS technical consultation on male circumcision and HIV prevention: research implications for policy and programming. Montreux, Switzerland, 6-8 March 2007. http://data.unaids.org/pub/Report/2007/ mc_recommendations_en.pdf
39. Halperin DT, Epstein H: Why is HIV prevalence so severe in southern Africa? The role of multiple concurrent partnerships and lack of male circumcision. S. Af. J. HIV Med. 26, 19-25 (2007).
40. Southern African Development Community (SADC) Meeting Report: experts think tank meeting on HIV prevention in high-prevalence countries in Southern Africa. Gaborone: SADC HIV and AIDS Unit, May 2006. http://www.sadc.int/attachments/news/SAD,CPrevBrochure.pdf
41. UNAIDS: Male circumcision: global trends and determinants of prevalence, safety and acceptability. Geneva: World Health Organisation 2007.